Integrated Wealth Concepts LLC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1737109 WALTHAM, MA

Position in HRTX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$137,128

+$60,730 QoQ

Shares Held

318,903

+233.9% QoQ

Ownership

0.168%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 161 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Integrated Wealth Concepts LLC holds $51,111,338 across 302 Biotechnology names. HRTX ranks #42 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	152,216	$8,709,799
2	INVA	Innoviva, Inc.	350,575	$7,961,558
3	EXEL	Exelixis, Inc.	69,926	$3,804,673
4	VRTX	Vertex Pharmaceuticals Inc / Ma	6,994	$3,474,129
5	DNLI	Denali Therapeutics Inc.	102,241	$2,629,638
6	ALNY	Alnylam Pharmaceuticals, Inc.	6,692	$2,014,492
7	INCY	Incyte Corp	17,318	$1,963,168
8	TLX	Telix Pharmaceuticals Ltd	164,397	$1,895,497

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$137,128	318,903	+233.9%	Shares	Sole	2026-08-12
2026-03-31	$76,398	95,498	+0.3%	Shares	Sole	2026-05-15
2025-12-31	$123,726	95,174	-2.5%	Shares	Sole	2026-02-13
2025-09-30	$122,969	97,595	+3.4%	Shares	Sole	2025-11-14
2025-06-30	$195,418	94,405	+0.1%	Shares	Sole	2025-08-14
2025-03-31	$207,471	94,305	-15.1%	Shares	Sole	2025-05-15
2024-12-31	$169,956	111,083	+127.7%	Shares	Sole	2025-02-14
2024-09-30	$97,068	48,778	-3.9%	Shares	Sole	2024-11-14
2024-06-30	$177,723	50,778	+4.1%	Shares	Sole	2024-08-14
2024-03-31	$135,115	48,778	+52.4%	Shares	Sole	2024-05-15
2023-12-31	$54,400	32,000	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.